https://www.selleckchem.com/pr....oducts/tenapanor.htm
9±0.5%) and control (93.8±0.6%). The early postoperative satisfaction in control group was much lower than HBOT group (52.9% vs 88.2%), whereas all patients showed satisfaction with the final result. Hyperbaric oxygen therapy is able to minimize the postsurgical follicle shedding and lead to less folliculitis and itching, which provides evidence for HBOT to act as an adjuvant therapy for hair transplantation surgery. Hyperbaric oxygen therapy is able to minimize the postsurgical follicle shedding and lead to less folliculitis and itch
Like
Comment
Share
